Banibrata Das

Trifluoroethoxy‐Coating Improves the Axial Ligand Substitution of Subphthalocyanine

Norio Shibata, Banibrata Das, Etsuko Tokunaga et al. · Chemistry - A European Journal · 2010 · 48 citations · Full text

Natural Sciences, Chemistry, Materials Science +11

Development of a Highly Potent D₂/D₃ Agonist and a Partial Agonist from Structure–Activity Relationship Study of <i>N</i>⁶-(2-(4-(1<i>H</i>-Indol-5-yl)piperazin-1-yl)ethyl)-<i>N</i>⁶-propyl-4,5,6,7-tetrahydrobenzo[<i>d</i>]thiazole-2,6-diamine Analogues: Implication in the Treatment of Parkinson’s Disease

Banibrata Das, Seenuvasan Vedachalam, Dan Luo et al. · Journal of Medicinal Chemistry · 2015 · 41 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

A Novel Iron(II) Preferring Dopamine Agonist Chelator as Potential Symptomatic and Neuroprotective Therapeutic Agent for Parkinson’s Disease

Banibrata Das, Ashoka Kandegedara, Liping Xu et al. · ACS Chemical Neuroscience · 2017 · 36 citations

Medicine, Medicinal Chemistry, Pharmacology +16

A novel iron (II) preferring dopamine agonist chelator D-607 significantly suppresses α-syn- and MPTP-induced toxicities in vivo

Banibrata Das, Subramanian Rajagopalan, Gnanada S. Joshi et al. · Neuropharmacology · 2017 · 35 citations · Full text

Medicine, Pharmacology, Toxicology +7

Design, Synthesis, and Pharmacological Characterization of Carbazole Based Dopamine Agonists as Potential Symptomatic and Neuroprotective Therapeutic Agents for Parkinson’s Disease

Asma S.mohamed Elmabruk, Banibrata Das, Deepthi Yedlapudi et al. · ACS Chemical Neuroscience · 2018 · 35 citations

Pharmacy, Medicinal Chemistry, Pharmacology +17